One moment, processing...

Printer-friendly version

What's Hot

QUICK LINKS

ACRP UPDATES

First Assignment Due Monday, 27th

Upload your assignment by May 27th so that your items can be available for review at the June Exam Committee meeting.

A link to register for the points will be sent during the first week of June and writers' feedback (for all itmes reviewed) will be sent within a week following the Committee meeting.

Networking Event in Edmonton, Alberta

The ACRP Canadian Chapter is pleased to invite you to an evening of socialization and networking with your fellow clinical research professionals on Thursday June 6, 2013 between 5:30 – 7:30pm MDT at the home of Doni Danforth in Edmonton, Alberta.

To obtain the address and directions, please RSVP to Doni at yesno@telusplanet.net. ACRP members and non-members welcome. Light refreshments will be provided.

Looking forward to having you join us!

NEW DOCUMENTS

Confidentiality Agreement and Conflict of Interest...

By: Jennifer Witebsky May 09, 2013 8:15 AM
Posted in: Academy Item Writers

MyItemWriter App Tutorial

By: Jennifer Witebsky May 07, 2013 9:11 AM
Posted in: Academy Item Writers

A 15 minute step-by-step audio/visual tutorial for using the MyItemWriter App and uploading items...

Item Writer Cheat Sheet- MyItemWriter for PCs

By: Jennifer Witebsky May 01, 2013 2:07 PM
Posted in: Academy Item Writers

How to get started, and how to upload your final items in MyItemWriter App (for PCs version)

FOLLOW ACRP ON

LinkedInFacebookTwitterYouTube

In the Know

LATEST DISCUSSIONS

CLINICAL RESEARCH NEWS

FDA Updates Safety Study Draft Guidance, Responds to Comments

5/22/2013 3:30:00 PM

The FDA has updated its draft guidance on best practices for conducting safety studies using electronic healthcare data sets after receiving more than 400 comments on its recommendations.

FMT Qualifies as Biological Product, Requires IND Filing for Trials: FDA

5/22/2013 3:30:00 PM

The FDA recently informed a group of gastroenterological specialists that fecal microbiota transplantation (FMT), also known as a stool transplant, should be considered a biological product under agency oversight when treating Clostridium difficile (C. difficile) infection.

Lilly Halts Phase III Trial of Non-Hodgkin’s Lymphoma Drug

5/22/2013 3:30:00 PM

Eli Lilly has put the brakes on a Phase III trial of its non-Hodgkin’s lymphoma (NHL) drug enzastaurin after it failed to meet its primary endpoint.

More News

Our Community

GETTING STARTED

STEP ONE
Login with your Username and Password.

STEP TWO
Customize your Profile and Preferences.

STEP THREE
Adjust your eForum notifications settings; go to Discussions, click on My Subscriptions.

STEP FOUR
Start a conversation; Post a Message in one of the Discussions.

STEP FIVE
Start networking; go to the Directory and Find a Member to connect with.

Visit ACRP on YouTube

Need more help? Visit our YouTube page and watch several Video Tutorials.

OUR ADVERTISERS

PAST WEEK'S TOP CONTRIBUTORS

  1. Mary Lou Brunkow

    Clinical List America
    Columbia, SC

    603 Points

  2. Veronica Baker

    Novo Nordisk Inc.
    Chicago, IL

    152 Points

  3. Connie Clark

    Anterios, Inc.
    New York, NY

    141 Points

MEMBERSHIP

Join ACRP
Learn About Benefits

RECENT BLOGS